Shares of Orgenesis Inc. (NASDAQ:ORGS – Get Free Report) were up 132.5% during mid-day trading on Friday . The company traded as high as $0.3720 and last traded at $0.3720. Approximately 213 shares were traded during mid-day trading, a decline of 81% from the average daily volume of 1,098 shares. The stock had previously closed at $0.16.
Orgenesis Trading Up 132.5%
The stock has a market capitalization of $1.92 million, a price-to-earnings ratio of -0.03 and a beta of 3.14. The firm has a 50-day moving average of $0.38 and a 200 day moving average of $0.38.
About Orgenesis
Orgenesis, Inc is a cell and gene therapy company that develops and commercializes point-of-care manufacturing platforms for autologous and allogeneic therapies. The company offers an end-to-end solution that spans from R&D through clinical and commercial production, targeting applications in oncology, neurology, and various rare diseases. Orgenesis’ technology platforms are designed to streamline the complex processes involved in cell isolation, genetic modification, expansion and cryopreservation.
The company’s flagship offering is its automated Prodigy® platform, which integrates cell processing workflows into a closed, single-use system.
Further Reading
- Five stocks we like better than Orgenesis
- 3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
- Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
- Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
- This Dividend ETF Choice Could Shape Your Income Strategy Through 2026
Receive News & Ratings for Orgenesis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orgenesis and related companies with MarketBeat.com's FREE daily email newsletter.
